DESCRIPTION
Conferences take place on the fourth Wednesday of each month from 12:00pm - 1:30pm. Exceptions will be noted in the notifications.

LEARNING OBJECTIVES

Upon completion of this activity, participants should be able to:

• Define appropriate management of complex endocrinopathies based on latest treatment guidelines, newer technology where applicable, and newer pharmacotherapy.
• Identify the key strategies to best communicate with patients and establish an effective relationship in a model of long-term care and follow up, or in consultation with limited follow up.
• Practice a smooth transition, and coordination of care for patients with pediatric endocrinopathies transferring under the care of adult endocrinologists at Mayo Clinic Arizona.
• Determine proper acute inpatient management of diabetes mellitus, and related comorbidities.
• Determine proper acute inpatient management of endocrinopathies.
• Improve knowledge base of endocrinologic diseases.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CREDIT STATEMENT(S):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 1.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Summary
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with ineligible companies:
None

Relevant financial relationships have been mitigated. 

No relevant financial relationship(s) with ineligible companies:
Eleanna De Filippis, M.D., Ph.D.; Bithika M. Thompson, M.D.; Mary E. Boyle, APRN, MSN, MBA, CNP; Susana Shephard, M.B.A.; Sara McCarty

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here.

COURSE DIRECTORS
Eleanna De Filippis, MD, PhD

ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.